Literature DB >> 11054723

A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype.

P Sarathchandra1, F M Pope, M V Kayser, S Y Ali.   

Abstract

A detailed morphological study was carried out using light and electron microscopy on 36 bone specimens from patients suffering from osteogenesis imperfecta (OI) and 20 age- and site-matched control bone specimens. The findings were grouped into the clinical types of OI according to the Sillence classification. The morphological and ultrastructural alterations observed in OI bone correlate well with clinical severity. Thus, OI type I, the mildest type, showed the least abnormalities in bone ultrastructure. OI type IV closely resembled type I, with only minor abnormalities in the bone cells and osteoid. OI type III showed abnormalities in the structure and distribution of osteoid collagen fibrils, whilst OI type II, the lethal form, revealed many varied abnormalities such as thin cortical bone, sparse trabecular bone, increased numbers of osteoclasts and osteocytes, thin osteoid with thin collagen fibrils, and patchy mineralization. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054723     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH704>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

1.  Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Authors:  Zhaoyong Li; Mohammad Q Hassan; Mohammed Jafferji; Rami I Aqeilan; Ramiro Garzon; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

Review 2.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

3.  Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.

Authors:  Ingo Grafe; Stefanie Alexander; Tao Yang; Caressa Lietman; Erica P Homan; Elda Munivez; Yuqing Chen; Ming Ming Jiang; Terry Bertin; Brian Dawson; Franklin Asuncion; Hua Zhu Ke; Michael S Ominsky; Brendan Lee
Journal:  J Bone Miner Res       Date:  2016-02-12       Impact factor: 6.741

4.  Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice.

Authors:  Hiroshi Sekiya; Tomohiko Murakami; Atsushi Saito; Shin-Ichiro Hino; Kenji Tsumagari; Kimiko Ochiai; Kazunori Imaizumi
Journal:  J Bone Miner Metab       Date:  2009-12-19       Impact factor: 2.626

Review 5.  Genetic causes and mechanisms of Osteogenesis Imperfecta.

Authors:  Joohyun Lim; Ingo Grafe; Stefanie Alexander; Brendan Lee
Journal:  Bone       Date:  2017-02-15       Impact factor: 4.398

6.  Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.

Authors:  Matthias Mähr; Stéphane Blouin; Martina Behanova; Barbara M Misof; Francis H Glorieux; Jochen Zwerina; Frank Rauch; Markus A Hartmann; Nadja Fratzl-Zelman
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta.

Authors:  Ingo Grafe; Tao Yang; Stefanie Alexander; Erica P Homan; Caressa Lietman; Ming Ming Jiang; Terry Bertin; Elda Munivez; Yuqing Chen; Brian Dawson; Yoshihiro Ishikawa; Mary Ann Weis; T Kuber Sampath; Catherine Ambrose; David Eyre; Hans Peter Bächinger; Brendan Lee
Journal:  Nat Med       Date:  2014-05-04       Impact factor: 53.440

8.  Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim).

Authors:  Sarah M Zimmerman; Melissa E Heard-Lipsmeyer; Milena Dimori; Jeff D Thostenson; Erin M Mannen; Charles A O'Brien; Roy Morello
Journal:  Bone Rep       Date:  2018-07-02

9.  Histopathology of osteogenesis imperfecta bone. Supramolecular assessment of cells and matrices in the context of woven and lamellar bone formation using light, polarization and ultrastructural microscopy.

Authors:  Frederic Shapiro; Kathleen Maguire; Srilatha Swami; Hui Zhu; Evelyn Flynn; Jamie Wang; Joy Y Wu
Journal:  Bone Rep       Date:  2020-12-01

10.  Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases.

Authors:  Lihui Chen; Gao Gao; Li Shen; Hua Yue; Ge Zhang; Zhenlin Zhang
Journal:  Dis Markers       Date:  2022-09-10       Impact factor: 3.464

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.